Biomea Fusion News

MEME stocks are back strongly! GME surged nearly 180% in two days. Who will be next?

The agency believes that more retail traders will join this trend in the next few days, but the possibility of reaching the level of 2021 is still relatively low.

Futu NewsMay 15 05:10

Biomea Fusion Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Biomea Fusion Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow JonesMay 3 14:59

HC Wainwright & Co. : Biomea Fusion (BMEA.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $50.00.

HC Wainwright & Co. : Biomea Fusion (BMEA.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $50.00.

Zhitong FinanceMay 3 14:50

HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $50 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $50 price target.

BenzingaMay 3 14:49

Biomea Fusion Is Maintained at Neutral by JP Morgan

Biomea Fusion Is Maintained at Neutral by JP Morgan

Dow JonesMay 3 10:32

JP Morgan Maintains Neutral on Biomea Fusion, Raises Price Target to $15

JP Morgan analyst Eric Joseph maintains Biomea Fusion with a Neutral and raises the price target from $14 to $15.

Analyst UpgradesMay 3 10:22

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA), Repligen (RGEN) and Agenus (AGEN)

TipRanksMay 3 06:42

Barclays Sticks to Its Buy Rating for Biomea Fusion (BMEA)

TipRanksMay 3 05:41

Biomea Fusion GAAP EPS of -$1.09 Misses by $0.02

Seeking AlphaMay 3 00:50

Biomea Fusion (BMEA.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $0; earnings per share of -1.09 dollars, previous value of -0.98 dollars, and expected value of -0.99 dollars.

Biomea Fusion (BMEA.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $0; earnings per share of -1.09 dollars, previous value of -0.98 dollars, and expected value of -0.99 dollars.

Zhitong FinanceMay 2 18:00

Biomea Fusion Q1 EPS $(1.09) Misses $(0.91) Estimate

Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(0.91) by 19.78 percent. This is a 11.22 percent decrease over losses of $(0.

BenzingaMay 2 16:12

Biomea Fusion 1Q Loss/Shr $1.09 >BMEA

Biomea Fusion 1Q Loss/Shr $1.09 >BMEA

Dow JonesMay 2 15:08

Press Release: Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights

Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights -- Reported positive data from the escalation portion of Phase 1/2 study (COVALENT-111) in type 2 diabetes

Dow JonesMay 2 15:05

DJT, BGFV and REAL Are Among After Hour Movers

Seeking AlphaApr 15 16:21

Biomea Fusion Price Target Maintained With a $70.00/Share by Oppenheimer

Biomea Fusion Price Target Maintained With a $70.00/Share by Oppenheimer

Dow JonesApr 3 09:11

Oppenheimer Maintains Outperform on Biomea Fusion, Maintains $70 Price Target

Oppenheimer analyst Hartaj Singh maintains Biomea Fusion with a Outperform and maintains $70 price target.

Analyst UpgradesApr 3 09:01

Biomea Fusion Drops as JPMorgan Downgrades on Data for Lead Asset

Seeking AlphaApr 2 12:18

Biomea Fusion Cut to Neutral From Overweight by JP Morgan

Biomea Fusion Cut to Neutral From Overweight by JP Morgan

Dow JonesApr 2 09:32

JP Morgan Downgrades Biomea Fusion to Neutral, Lowers Price Target to $14

JP Morgan analyst Gavin Scott downgrades Biomea Fusion from Overweight to Neutral and lowers the price target from $51 to $14.

Analyst UpgradesApr 2 09:22

Biomea Fusion Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/02/2024 3.74% JP Morgan $51 → $14 Downgrades Overweight → Neutral 04/01/2024 270.51% HC Wainwright & Co

BenzingaApr 2 09:20